Liver Cirrhosis, Experimental
|
disease |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases
|
Experimental Model of Disease
|
870
|
|
0.300 |
None |
1.000 |
1 |
|
2014 |
2014 |
Peritoneal Neoplasms
|
group |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
10
|
|
0.300 |
None |
1.000 |
1 |
|
2013 |
2013 |
Carcinomatosis of peritoneal cavity
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
107
|
3
|
0.300 |
None |
1.000 |
1 |
|
2013 |
2013 |
Malignant mesothelioma
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
420
|
12
|
0.300 |
None |
1.000 |
1 |
|
2013 |
2013 |
Vital capacity
|
phenotype |
|
Clinical Attribute
|
430
|
746
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Birth Weight
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Organism Attribute
|
214
|
369
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Infant length
|
phenotype |
|
Finding
|
10
|
14
|
0.100 |
None |
1.000 |
1 |
1
|
2015 |
2015 |
Adult B Acute Lymphoblastic Leukemia
|
disease |
|
Neoplastic Process
|
74
|
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Adult Acute Lymphocytic Leukemia
|
disease |
|
Neoplastic Process
|
860
|
154
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Well Differentiated Oligodendroglioma
|
disease |
Neoplasms
|
Neoplastic Process
|
270
|
22
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Biliary stricture
|
disease |
Digestive System Diseases
|
Anatomical Abnormality
|
17
|
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Thyroid carcinoma
|
disease |
Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
1175
|
145
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Recurrent tumor
|
phenotype |
|
Neoplastic Process
|
735
|
33
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Pre B-cell acute lymphoblastic leukemia
|
disease |
|
Neoplastic Process
|
90
|
5
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Adult Oligodendroglioma
|
disease |
Neoplasms
|
Neoplastic Process
|
154
|
19
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Childhood B Acute Lymphoblastic Leukemia
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
99
|
4
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
296
|
9
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Adult Pilocytic Astrocytoma
|
disease |
Neoplasms
|
Neoplastic Process
|
92
|
10
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Childhood Oligodendroglioma
|
disease |
Neoplasms
|
Neoplastic Process
|
154
|
19
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Squamous cell carcinoma of esophagus
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
2053
|
329
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Carcinoma, Small Cell
|
disease |
Neoplasms
|
Neoplastic Process
|
185
|
7
|
0.010 |
None |
1.000 |
1 |
|
2007 |
2007 |
Malignant Squamous Cell Neoplasm
|
disease |
Neoplasms
|
Neoplastic Process
|
193
|
12
|
0.010 |
None |
1.000 |
1 |
|
2003 |
2003 |
Glioblastoma Multiforme
|
disease |
Neoplasms
|
Neoplastic Process
|
3197
|
186
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Resistance to Insulin-Like Growth Factor I
|
disease |
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities
|
Disease or Syndrome
|
55
|
4
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Secondary Neoplasm
|
group |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
2492
|
85
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |